SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387308-15-000040
Filing Date
2015-05-13
Accepted
2015-05-13 14:27:18
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 361378
2 EX 31,1 ex311.htm EX-31.1 9826
3 EX 32.1 ex321.htm EX-32.1 5802
  Complete submission text file 0001387308-15-000040.txt   1673503

Data Files

Seq Description Document Type Size
4 EX 101.INS axim-20150331.xml EX-101.INS 104726
5 EX 101.SCH axim-20150331.xsd EX-101.SCH 29649
6 EX 101.CAL axim-20150331_cal.xml EX-101.CAL 4028
7 EX 101.DEF axim-20150331_def.xml EX-101.DEF 16502
8 EX 101.LAB axim-20150331_lab.xml EX-101.LAB 137283
9 EX 101.PRE axim-20150331_pre.xml EX-101.PRE 88198
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 15857759
SIC: 4953 Refuse Systems